InterventionsHuman trial
Bofanglutide (GZR18), a Novel GLP-1RA, Improved Glycemic Control and Cardiometabolic Risk Factors in Chinese Patients with T2D
ADA Scientific Sessions 2025 Abstract
The paper
LI W, LIU M, DONG R et al.
ADA Scientific Sessions 2025 Abstract · 13 Jun 2025
Presented at ADA Scientific Sessions 2025 · Poster 769-P